Essex Financial Services’s ImmuCell ICCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.6K Hold
11,000
﹤0.01% 786
2025
Q4
$67.7K Hold
11,000
﹤0.01% 778
2025
Q3
$68.8K Hold
11,000
﹤0.01% 745
2025
Q2
$76.6K Hold
11,000
0.01% 685
2025
Q1
$52.7K Hold
11,000
﹤0.01% 628
2024
Q4
$56.6K Hold
11,000
﹤0.01% 628
2024
Q3
$39.7K Hold
11,000
﹤0.01% 624
2024
Q2
$41.5K Hold
11,000
﹤0.01% 612
2024
Q1
$58.3K Hold
11,000
0.01% 539
2023
Q4
$56K Hold
11,000
0.01% 507
2023
Q3
$58.7K Sell
11,000
-3,000
-21% -$15.2K 0.01% 468
2023
Q2
$70K Buy
14,000
+300
+2% +$1.53K 0.01% 468
2023
Q1
$70K Buy
13,700
+2,700
+25% +$17.5K 0.01% 480
2022
Q4
$67K Hold
11,000
0.01% 471
2022
Q3
$82K Hold
11,000
0.01% 448
2022
Q2
$96K Hold
11,000
0.01% 470
2022
Q1
$106K Sell
11,000
-1,718
-14% -$14.8K 0.01% 497
2021
Q4
$102K Sell
12,718
-1,282
-9% -$11.5K 0.01% 492
2021
Q3
$131K Buy
+14,000
New +$132K 0.02% 457
2020
Q4
Sell
-20,000
Closed -$109K 330
2020
Q3
$109K Buy
+20,000
New +$111K 0.03% 279
2020
Q1
Sell
-21,600
Closed -$111K 260
2019
Q4
$111K Hold
21,600
0.03% 267
2019
Q3
$120K Buy
21,600
+600
+3% +$3.51K 0.04% 244
2019
Q2
$137K Hold
21,000
0.04% 235
2019
Q1
$133K Hold
21,000
0.04% 228
2018
Q4
$148K Sell
21,000
-2,776
-12% -$21.5K 0.05% 239
2018
Q3
$198K Hold
23,776
0.04% 275
2018
Q2
$162K Hold
23,776
0.04% 263
2018
Q1
$166K Hold
23,776
0.03% 337
2017
Q4
$209K Hold
23,776
0.05% 260
2017
Q3
$155K Hold
23,776
0.04% 270
2017
Q2
$174K Hold
23,776
0.04% 336
2017
Q1
$131K Hold
23,776
0.03% 318
2016
Q4
$141K Hold
23,776
0.03% 316
2016
Q3
$184K Hold
23,776
0.04% 293
2016
Q2
$164K Hold
23,776
0.04% 294
2016
Q1
$163K Hold
23,776
0.04% 299
2015
Q4
$176K Hold
23,776
0.04% 306
2015
Q3
$141K Hold
23,776
0.04% 309
2015
Q2
$187K Hold
23,776
0.05% 312
2015
Q1
$149K Hold
23,776
0.04% 313
2014
Q4
$116K Hold
23,776
0.03% 315
2014
Q3
$118K Hold
23,776
0.04% 293
2014
Q2
$105K Hold
23,776
0.03% 298
2014
Q1
$114K Hold
23,776
0.04% 280
2013
Q4
$101K Hold
23,776
0.03% 273
2013
Q3
$112 Hold
23,776
0.04% 253
2013
Q2
$89K Buy
+23,776
New +$85.2K 0.03% 260

Other funds holding ICCC

Essex Financial Services's ICCC Position: Q1 2026 in Review

Essex Financial Services held its ImmuCell (ICCC) position steady in Q1 2026 at 11,000 shares worth $69.6K. The position accounts for ﹤0.01% of the portfolio, ranked #786.

Essex Financial Services first reported a position in ICCC in Q2 2013 and has held it in 47 quarters since. The position peaked at $209K in Q4 2017. 27 funds tracked by Wall St. Rank hold ICCC as of Q1 2026.

  • Essex Financial Services held 11,000 shares of ImmuCell worth $69.6K as of Q1 2026.
  • Essex Financial Services left its ImmuCell share count unchanged in Q1 2026.
  • ImmuCell made up ﹤0.01% of Essex Financial Services's portfolio in Q1 2026, its #786 holding.
  • Essex Financial Services first reported a position in ImmuCell in Q2 2013 and has held it in 47 quarters since.
  • Essex Financial Services's ImmuCell position peaked at $209K in Q4 2017.
  • 27 funds tracked by Wall St. Rank held ImmuCell as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.